资产负债表(Chemomab Therapeutics Ltd ADR)
2023年年报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
---|---|---|---|---|---|---|---|
截止日期 | 2023-12-31 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
流动资产: | |||||||
现金及现金等价物(元) | 9,292,000.00 | 10,382,000.00 | 20,765,000.00 | 13,519,000.00 | 10,741,000.00 | 9,883,000.00 | 13,827,000.00 |
受限制存款及现金流动(元) | 10,568,000.00 | 16,281,000.00 | 12,018,000.00 | 26,451,000.00 | 35,725,000.00 | 41,841,000.00 | 43,579,000.00 |
预付款项及其他应收款流动(元) | 1,037,000.00 | 1,042,000.00 | 995,000.00 | 1,766,000.00 | 2,259,000.00 | 3,106,000.00 | 1,934,000.00 |
流动资产合计(元) | 20,897,000.00 | 27,705,000.00 | 33,778,000.00 | 41,736,000.00 | 48,725,000.00 | 54,830,000.00 | 59,340,000.00 |
非流动资产: | |||||||
物业、厂房及设备(元) | 303,000.00 | 338,000.00 | 352,000.00 | 367,000.00 | 380,000.00 | 355,000.00 | 358,000.00 |
受限制存款及现金非流动(元) | - | - | - | - | 77,000.00 | 77,000.00 | 85,000.00 |
预付款项及其他长期应收款非流动(元) | 559,000.00 | 646,000.00 | 690,000.00 | 733,000.00 | 776,000.00 | - | - |
非流动资产其他项目(元) | 392,000.00 | 160,000.00 | 193,000.00 | 227,000.00 | 261,000.00 | 1,116,000.00 | 1,173,000.00 |
非流动资产合计(元) | 1,254,000.00 | 1,144,000.00 | 1,235,000.00 | 1,327,000.00 | 1,494,000.00 | 1,548,000.00 | 1,616,000.00 |
总资产(元) | 22,151,000.00 | 28,849,000.00 | 35,013,000.00 | 43,063,000.00 | 50,219,000.00 | 56,378,000.00 | 60,956,000.00 |
流动负债: | |||||||
融资租赁负债流动(元) | 76,000.00 | 108,000.00 | 115,000.00 | 123,000.00 | 126,000.00 | 132,000.00 | 116,000.00 |
应付账款及票据(元) | 516,000.00 | 2,347,000.00 | 2,217,000.00 | 1,688,000.00 | 1,247,000.00 | 1,433,000.00 | 1,487,000.00 |
应付薪酬和福利(元) | 823,000.00 | 1,867,000.00 | 1,501,000.00 | 1,560,000.00 | 1,527,000.00 | 1,117,000.00 | 666,000.00 |
其他应付款及应计费用(元) | 3,423,000.00 | 2,503,000.00 | 3,164,000.00 | 3,378,000.00 | 2,577,000.00 | 1,712,000.00 | 1,248,000.00 |
流动负债合计(元) | 4,838,000.00 | 6,825,000.00 | 6,997,000.00 | 6,749,000.00 | 5,477,000.00 | 4,394,000.00 | 3,517,000.00 |
非流动负债: | |||||||
融资租赁负债非流动(元) | 316,000.00 | 33,000.00 | 62,000.00 | 91,000.00 | 118,000.00 | 148,000.00 | 203,000.00 |
非流动负债合计(元) | 316,000.00 | 33,000.00 | 62,000.00 | 91,000.00 | 118,000.00 | 148,000.00 | 203,000.00 |
总负债(元) | 5,154,000.00 | 6,858,000.00 | 7,059,000.00 | 6,840,000.00 | 5,595,000.00 | 4,542,000.00 | 3,720,000.00 |
股东权益: | |||||||
库存股(元) | - | -1,218,000.00 | -1,218,000.00 | -1,218,000.00 | - | - | - |
股本溢价(元) | 105,675,000.00 | 103,751,000.00 | 101,744,000.00 | 101,260,000.00 | 100,171,000.00 | 99,303,000.00 | 98,513,000.00 |
留存收益(元) | -88,678,000.00 | -80,542,000.00 | -72,572,000.00 | -63,819,000.00 | -55,547,000.00 | -47,467,000.00 | -41,277,000.00 |
归属于母公司股东权益(元) | 16,997,000.00 | 21,991,000.00 | 27,954,000.00 | 36,223,000.00 | 44,624,000.00 | 51,836,000.00 | 57,236,000.00 |
股东权益合计(元) | 16,997,000.00 | 21,991,000.00 | 27,954,000.00 | 36,223,000.00 | 44,624,000.00 | 51,836,000.00 | 57,236,000.00 |
负债及股东权益合计(元) | 22,151,000.00 | 28,849,000.00 | 35,013,000.00 | 43,063,000.00 | 50,219,000.00 | 56,378,000.00 | 60,956,000.00 |
公告日期 | 2024-03-28 | 2023-08-14 | 2023-05-11 | 2023-03-20 | 2022-11-10 | 2022-08-12 | 2022-05-12 |
会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
审计意见 | |||||||
核数师 |